Scotts Miracle-Gro (SMG) has drawn fresh attention after recent trading left the shares with a 1-day return of about a 2% decline and a past-month return of roughly a 14% decline.
See our latest analysis for Scotts Miracle-Gro.
The recent 1-day and 7-day share price declines sit against a 90-day share price return of 5.09% and a 1-year total shareholder return of 15.44%. This suggests momentum has faded recently after a stronger stretch.
If you are looking beyond Scotts Miracle-Gro for ideas in related areas of the market, this could be a good time to check out 20 top founder-led companies
With Scotts Miracle-Gro trading around $60.65, and an intrinsic value estimate plus analyst targets that imply roughly a 24% to 25% discount, the key question is whether this signals a genuine buying opportunity or if the market is already pricing in future growth.
Most Popular Narrative: 39.5% Overvalued
Compared with the last close of $60.65, the most followed narrative pegs Scotts Miracle-Gro’s fair value at $43.49, putting a clear gap between price and narrative valuation.
This is not a hypergrowth story. It is a durability story. As food security, indoor agriculture, and yield efficiency gain importance globally, companies with cultivation expertise stand to benefit quietly rather than explosively.
Want to see what is backing that durability label, according to yiannisz? The narrative leans heavily on earnings power, margins, and where cultivation-focused cash flows might settle.
Result: Fair Value of $43.49 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors still need to watch for renewed pressure in cannabis cultivation, as well as any setback in margin recovery that could weaken the cultivation durability argument.
Find out about the key risks to this Scotts Miracle-Gro narrative.
Another Angle on Value: Market Multiples vs Narrative
That 39.5% overvalued narrative sits awkwardly next to how the market is actually pricing Scotts Miracle-Gro. On a P/E of 21.5x, the shares trade below both the US Chemicals industry at 27.4x and peers at 28.4x, and even below an estimated fair ratio of 23.9x.
This gap suggests the market is not paying a premium for SMG compared with its sector, even though the narrative flags a rich valuation. The real question for you is whether that discount on earnings reflects hidden risk or a misread on the durability story.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mixed signals on value and sentiment, this is a moment to look at the numbers yourself and decide how you feel about the trade off between risks and rewards. To help frame that view, make sure you check the 5 key rewards and 3 important warning signs.
Looking for more investment ideas?
If Scotts Miracle-Gro raised good questions for you, consider scanning a wider set of opportunities so your portfolio is not tied to a single story.
- Target potential mispriced opportunities by checking out companies in the 62 high quality undervalued stocks that combine quality with appealing valuation signals.
- Strengthen your focus on resilience by reviewing the 64 resilient stocks with low risk scores and see which businesses stand out on lower risk scores.
- Spot underfollowed opportunities early by searching through the screener containing 25 high quality undiscovered gems before attention and liquidity potentially increase.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com